Search Within

Mark Blaine Geyer

Refine Results
Formats
  1. Journal Article (9)
  2. Meeting Abstract (5)
Groups
  1. Adult Leukemia (14)
  2. Center for Hematologic Malignancies (14)
  3. Hematologic Oncology, Division of (14)
  4. Leukemia Service (14)
  5. Hematologic Malignancies Research (6)
  6. Molecular Pharmacology and Chemistry Program Faculty (4)

More Groups

People
  1. Jae Park (8)
  2. Renier Brentjens (6)
  3. Brigitte Senechal (4)
  4. Isabelle Riviere (4)
  5. Michel Sadelain (4)
  6. Xiuyan Wang (4)

More People

Years
  1. 2019 (2)
  2. 2018 (5)
  3. 2017 (2)
  4. 2016 (4)
  5. 2015 (1)
Publications
  1. Blood (5)
  2. Leukemia and Lymphoma (2)
  3. Bone Marrow Transplantation (1)
  4. Clinical Cancer Research (1)
  5. Clinical Lymphoma, Myeloma and Leukemia (1)
  6. Cytotherapy (1)

More Publications

Publishers
  1. American Society of Hematology (5)
  2. Nature Publishing Group (2)
  3. Taylor & Francis Group (2)
  4. American Association for Cancer Research (1)
  5. Elsevier Inc. (1)
  6. Elsevier Science Ltd. (1)

More Publishers

Results (14)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia
    Journal Article

    Hochberg, J.; Zahler, S.; Geyer, M. B.; Chen, N.; Krajewski, J.; Harrison, L.; Militano, O.; Ozkaynak, M. F.; Cheerva, A. C.; Talano, J.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • First car to pass the road test: Tisagenlecleucel's drive to FDA approval
    Journal Article

    Geyer, M. B.
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of MRD negativity in adults ages 18-60 with Philadelphia chromosome-negative acute lymphoblastic leukemia and lymphoblastic lymphoma
    Meeting Abstract

    Geyer, M. B.; Ritchie, E. K.; Rao, A. V.; Cazacu, M. I.; Vemuri, S.; Tallman, M. S.; Douer, D.; Park, J. H.
    Blood (2018)

    Fulltext@MSK | Save
  • Autologous CD19-Targeted CAR T cells in patients with residual CLL following initial purine analog-based therapy
    Journal Article

    Geyer, M. B.; Rivière, I.; Sénéchal, B.; Wang, X.; Wang, Y.; Purdon, T. J.; Hsu, M.; Devlin, S. M.; Halton, E.; Lamanna, N.; more...
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells
    Journal Article

    Geyer, M. B.; Manjunath, S. H.; Evans, A. G.; Park, J. H.; Davila, M. L.; Cutler, C. S.; Wang, X.; Wang, Y.; Senechal, B.; Rivière, I.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • A comparison of immune reconstitution following human placenta-derived stem cells (HPDSC) with umbilical cord blood transplantation (UCBT) vs. UCBT alone in pediatric recipients with malignant and non-malignant diseases
    Meeting Abstract

    Sandhu, S.; Flower, A.; Geyer, M.; Harrison, L.; Shi, Q.; Pulsipher, M.; Giller, R.; Morris, E.; Klejmont, L.; Ayello, J.; more...
    Journal of Clinical Immunology (2018)

    Fulltext@MSK | Save
  • Digging deeper in relapsed acute lymphoblastic leukemia: Impact of MRD status on outcome in second remission
    Journal Article

    Geyer, M. B.; Tallman, M. S.
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Clinical and pathological features of B-cell acute lymphoblastic leukemia following maintenance treatment with lenalidomide for multiple myeloma
    Meeting Abstract

    Geyer, M. B.; Shaffer, B. C.; Landau, H.; Hassoun, H.; Famulare, C.; Roshal, M.; Dogan, A.; Arcila, M. E.; Park, J. H.
    Blood (2017)

    Fulltext@MSK | Save
  • Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis
    Journal Article

    Geyer, M. B.; Hsu, M.; Devlin, S. M.; Tallman, M. S.; Douer, D.; Park, J. H.
    Blood (2017)

    Fulltext@MSK | Save
  • Implications of concurrent ibrutinib therapy on CAR T-cell manufacturing and phenotype and on clinical outcomes following CD19-targeted CAR T-cell administration in adults with relapsed/refractory CLL
    Meeting Abstract

    Geyer, M. B.; Park, J. H.; Riviere, I.; Senechal, B.; Wang, X.; Purdon, T. J.; Sadelain, M. W.; Brentjens, R. J.
    Blood (2016)

    Fulltext@MSK | Save